Based on these finding we decided to explore whether a C-peptide mechanistic model or an adiposity model (based on BMI) could explain early changes in lipids in T2D by comparing subjects with T2D, who are classically insulin resistant, to non-remitters who are relatively not insulin resistant, while using the controls and remitters as comparators. Here, INS is linked to type 2 diabetes mellitus.